2-214757506-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000465.4(BARD1):​c.1569-4951T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.444 in 151,868 control chromosomes in the GnomAD database, including 15,038 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 15038 hom., cov: 31)

Consequence

BARD1
NM_000465.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.109

Publications

2 publications found
Variant links:
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
BARD1 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.485 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000465.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
NM_000465.4
MANE Select
c.1569-4951T>A
intron
N/ANP_000456.2
BARD1
NM_001282543.2
c.1512-4951T>A
intron
N/ANP_001269472.1
BARD1
NM_001282545.2
c.216-4951T>A
intron
N/ANP_001269474.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
ENST00000260947.9
TSL:1 MANE Select
c.1569-4951T>A
intron
N/AENSP00000260947.4
BARD1
ENST00000617164.5
TSL:1
c.1512-4951T>A
intron
N/AENSP00000480470.1
BARD1
ENST00000613706.5
TSL:1
c.1161-4951T>A
intron
N/AENSP00000484976.2

Frequencies

GnomAD3 genomes
AF:
0.444
AC:
67366
AN:
151748
Hom.:
15016
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.479
Gnomad AMI
AF:
0.415
Gnomad AMR
AF:
0.395
Gnomad ASJ
AF:
0.436
Gnomad EAS
AF:
0.419
Gnomad SAS
AF:
0.502
Gnomad FIN
AF:
0.489
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.424
Gnomad OTH
AF:
0.458
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.444
AC:
67416
AN:
151868
Hom.:
15038
Cov.:
31
AF XY:
0.449
AC XY:
33305
AN XY:
74216
show subpopulations
African (AFR)
AF:
0.480
AC:
19845
AN:
41386
American (AMR)
AF:
0.395
AC:
6033
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.436
AC:
1515
AN:
3472
East Asian (EAS)
AF:
0.419
AC:
2163
AN:
5162
South Asian (SAS)
AF:
0.502
AC:
2413
AN:
4808
European-Finnish (FIN)
AF:
0.489
AC:
5146
AN:
10514
Middle Eastern (MID)
AF:
0.442
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
0.424
AC:
28833
AN:
67946
Other (OTH)
AF:
0.457
AC:
960
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1943
3887
5830
7774
9717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
632
1264
1896
2528
3160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.300
Hom.:
740
Bravo
AF:
0.431
Asia WGS
AF:
0.455
AC:
1578
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.74
DANN
Benign
0.31
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10190829; hg19: chr2-215622230; API